MicroPort CardioFlow Medtech Corp (HKSE:02160) Share Price

Company Profile

Business description
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
Contact
No. 1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Pudong New District
Shanghai201203
CHN
T: +86 2138954600
https://www.cardioflowmedtech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
417

Recommended

We think Microsoft stock is moderately undervalued.

Dan Romanoff, CPA | 30 October 2025

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.

Seth Goldstein, CFA | 30 October 2025

Well priced Aussie shares that offer a tax rebate.

Shani Jayamanne | 29 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,178.00	28.70	-0.31%
CAC 40	8,121.07	36.22	-0.44%
DAX 40	23,958.30	160.59	-0.67%
Dow JONES (US)	47,502.14	19.98	-0.04%
FTSE 100	9,717.25	42.81	-0.44%
HKSE	25,906.65	376.04	-1.43%
NASDAQ	23,723.77	142.63	0.60%
Nikkei 225	52,411.34	1,085.73	2.12%
NZX 50 Index	13,548.32	89.03	0.66%
S&P 500	6,839.13	16.79	0.25%
S&P/ASX 200	8,881.90	31.30	-0.35%
SSE Composite Index	3,954.79	32.11	-0.81%